ArticlePloS one2016

Targeted HIV-1 Latency Reversal Using CRISPR/Cas9-Derived Transcriptional Activator Systems.

Julia K Bialek et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.